Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A07918 | 32310756 | J Pharm Pharm Sci | Gamma glutamyl transferase - an underestimated marker for cardiovascular disease and the metabolic syndrome. | 2020 | Details |
| A07919 | 32309672 | Contemp Clin Trials Commun | Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH. | 2020 | Details |
| A07928 | 32306654 | Zhonghua Gan Zang Bing Za Zhi | [Diagnosis and treatment strategies for fatty liver when obesity coexists with alcohol consumption]. | 2020 | Details |
| A07930 | 32306652 | Zhonghua Gan Zang Bing Za Zhi | [Diagnosis and therapeutic strategies for non-obese type of non-alcoholic fatty liver diseases]. | 2020 | Details |
| A07944 | 32303161 | Curr Pharm Des | Semi-Quantitative Ultrasonographic Evaluation of NAFLD. | 2020 | Details |
| A07950 | 32301571 | Liver Int | Increasing liver fat is associated with progression of cardiovascular risk factors. | 2020 | Details |
| A07954 | 32300995 | Hepatol Int | Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population. | 2020 | Details |
| A07994 | 32285340 | Adv Ther | Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review. | 2020 | Details |
| A07999 | 32283679 | J Clin Med | Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) Is Independently Associated with Cardiovascular Risk in a Large Austrian Screening Cohort. | 2020 | Details |
| A08004 | 32282030 | Br Med Bull | Obeticholic acid-a new therapy in PBC and NASH. | 2020 | Details |
| A08007 | 32281324 | Korean Circ J | A Close Relationship between Non-Alcoholic Fatty Liver Disease Marker and New-Onset Hypertension in Healthy Korean Adults. | 2020 | Details |
| A08019 | 32279432 | Liver Int | Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation. | 2020 | Details |
| A08021 | 32279091 | Mamm Genome | Epigenetic contribution to obesity. | 2020 | Details |
| A08033 | 32274915 | Minerva Pediatr | Metabolic syndrome in children. | 2020 | Details |
| A08034 | 32274348 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations. | 2019 | Details |
| A08052 | 32268002 | Diabetes Metab Res Rev | Association of bedtime with the risk of non-alcoholic fatty liver disease among middle-aged and elderly Chinese adults with pre-diabetes and diabetes. | 2020 | Details |
| A08053 | 32267638 | Ned Tijdschr Geneeskd | [Non-alcoholic fatty liver disease; a full-bodied epidemic]. | 2020 | Details |
| A08068 | 32258528 | Transl Gastroenterol Hepatol | Nonalcoholic steatohepatitis recurrence after liver transplant. | 2020 | Details |
| A08070 | 32258522 | Transl Gastroenterol Hepatol | Peri-transplant renal dysfunction in patients with non-alcoholic steatohepatitis undergoing liver transplantation. | 2020 | Details |
| A08071 | 32258520 | Transl Gastroenterol Hepatol | Epidemiology of non-alcoholic and alcoholic fatty liver diseases. | 2020 | Details |
| A08093 | 32249283 | J Infect Dis | Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection. | 2020 | Details |
| A08096 | 32246926 | Exp Mol Pathol | Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in SHRSP5/Dmcr rat model. | 2020 | Details |
| A08117 | 32240838 | Atherosclerosis | Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease. | 2020 | Details |
| A08129 | 32237015 | Pediatr Diabetes | Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity. | 2020 | Details |
| A08134 | 32235172 | J Acquir Immune Defic Syndr | Brief Report: Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in Persons With HIV. | 2020 | Details |
| A08136 | 32232972 | J Diabetes Investig | New perspective on type 2 diabetes, dyslipidemia and non-alcoholic fatty liver disease. | 2020 | Details |
| A08165 | 32220662 | Atherosclerosis | Relationship of fibroblast growth factor 21 levels with inflammation, lipoproteins and non-alcoholic fatty liver disease. | 2020 | Details |
| A08168 | 32220085 | J Gastroenterol Hepatol | PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States. | 2020 | Details |
| A08203 | 32207258 | Endocrinol Metab (Seoul) | Impact of Skeletal Muscle Mass on Metabolic Health. | 2020 | Details |
| A08210 | 32203743 | Atherosclerosis | Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor. | 2020 | Details |
| A08225 | 32193478 | Sci Rep | The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index. | 2020 | Details |
| A08240 | 32190778 | Transl Gastroenterol Hepatol | Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates . | 2020 | Details |
| A08248 | 32189102 | Dig Dis Sci | Progression to Cirrhosis Leads to Improvement in Atherogenic Milieu. | 2020 | Details |
| A08251 | 32188385 | Curr Vasc Pharmacol | Non-Alcoholic Fatty Liver Disease and Vascular Disease. | 2021 | Details |
| A08256 | 32185691 | Indian J Gastroenterol | The predictive value of the hepatorenal index for detection of impaired glucose metabolism in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A08288 | 32168769 | Int J Mol Sci | Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08300 | 32161545 | Front Pharmacol | Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities. | 2020 | Details |
| A08314 | 32156227 | Curr Pharm Des | Modifiers of Liver-Related Manifestation in the Course of NAFLD. | 2020 | Details |
| A08315 | 32156140 | Ann Palliat Med | Association between non-alcoholic fatty liver disease and silent carotid plaque in Chinese aged population: a cross-sectional study. | 2020 | Details |
| A08317 | 32154399 | Heliyon | The advantages and disadvantages of sleeve gastrectomy; clinical laboratory to bedside review. | 2020 | Details |
| A08322 | 32152902 | Indian J Gastroenterol | Treatment of non-alcoholic fatty liver disease - Current perspectives. | 2020 | Details |
| A08333 | 32150036 | Transplantation | Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C. | 2020 | Details |
| A08335 | 32149276 | Food Chem X | Current intakes of trans-palmitoleic (trans-C16:1 n-7) and trans-vaccenic (trans-C18:1 n-7) acids in France are exclusively ensured by ruminant milk and ruminant meat: A market basket investigation. | 2020 | Details |
| A08336 | 32149275 | JHEP Rep | Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism. | 2019 | Details |
| A08339 | 32148405 | J Ginseng Res | Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity, hepatic steatosis, and insulin resistance in mice. | 2018 | Details |
| A08351 | 32145387 | Prostaglandins Other Lipid Mediat | Lipocalin-type prostaglandin D2 synthase deletion induces dyslipidemia and non-alcoholic fatty liver disease. | 2020 | Details |
| A08355 | 32145256 | J Hepatol | Update on NAFLD genetics: From new variants to the clinic. | 2020 | Details |
| A08367 | 32141917 | Am J Gastroenterol | Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk. | 2020 | Details |
| A08380 | 32134732 | J Basic Clin Physiol Pharmacol | Silymarin: not just another antioxidant. | 2020 | Details |
| A08400 | 32124690 | Curr Pharm Des | Epidemiology of Non-alcoholic Fatty Liver Disease in North America. | 2020 | Details |
| A08440 | 32110378 | Cell Biosci | RNA N6-methyladenosine: a promising molecular target in metabolic diseases. | 2020 | Details |
| A08444 | 32108506 | Scand J Clin Lab Invest | Human apolipoprotein CIII levels; evaluation of three assay methods. | 2020 | Details |
| A08452 | 32105577 | Circ Res | Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases. | 2020 | Details |
| A08453 | 32105003 | Turk J Pediatr | Cardiometabolic risk factors in Turkish children with hepatosteatosis. | 2019 | Details |
| A08458 | 32104026 | Diabetes Metab Syndr Obes | Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH. | 2020 | Details |
| A08460 | 32103588 | Mol Nutr Food Res | Regulation of Adipocyte and Macrophage Functions by mTORC1 and 2 in Metabolic Diseases. | 2020 | Details |
| A08480 | 32093016 | Cells | The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. | 2020 | Details |
| A08486 | 32091437 | Eur J Gastroenterol Hepatol | MRI-determined liver fat correlates with risk of metabolic syndrome in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A08500 | 32084429 | Metabolism | mTORC1-dependent protein synthesis and autophagy uncouple in the regulation of Apolipoprotein A-I expression. | 2020 | Details |
| A08510 | 32081727 | Mitochondrion | Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome. | 2020 | Details |
| A08511 | 32081018 | Rev Esp Enferm Dig | Mechanism of bariatric and metabolic surgery: beyond surgeons, gastroenterologists and endocrinologists. | 2020 | Details |
| A08516 | 32077613 | Liver Int | A diabetologist's perspective of non-alcoholic steatohepatitis (NASH): Knowledge gaps and future directions. | 2020 | Details |
| A08518 | 32077609 | Liver Int | Current management of non-alcoholic steatohepatitis. | 2020 | Details |
| A08540 | 32068022 | Gastroenterology | Metabolic Inflammation-A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease? | 2020 | Details |
| A08541 | 32067588 | J Am Heart Assoc | Longitudinal Association of Non-Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study. | 2020 | Details |
| A08553 | 32063504 | Ann Hepatol | Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening? | 2020 | Details |
| A08557 | 32061907 | Metabolism | Established and emerging factors affecting the progression of nonalcoholic fatty liver disease. | 2020 | Details |
| A08562 | 32061583 | Obes Res Clin Pract | Elevated 1-h post-load plasma glucose levels in normal glucose tolerance children with obesity is associated with early carotid atherosclerosis. | 2020 | Details |
| A08568 | 32058217 | Biomed Pharmacother | Iridoids of Valeriana fauriei contribute to alleviating hepatic steatosis in obese mice by lipophagy. | 2020 | Details |
| A08580 | 32053033 | Expert Opin Ther Targets | Emerging therapeutic targets for NASH: key innovations at the preclinical level. | 2020 | Details |
| A08582 | 32051820 | Can J Gastroenterol Hepatol | Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach. | 2020 | Details |
| A08586 | 32049638 | BMJ Open Diabetes Res Care | Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study. | 2020 | Details |
| A08587 | 32049637 | BMJ Open Diabetes Res Care | Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications. | 2020 | Details |
| A08588 | 32048436 | Obes Rev | Foetal and childhood exposure to famine and the risks of cardiometabolic conditions in adulthood: A systematic review and meta-analysis of observational studies. | 2020 | Details |
| A08591 | 32047809 | Biomed Res Int | Recombinant Lactococcus lactis Expressing Ling Zhi 8 Protein Ameliorates Nonalcoholic Fatty Liver and Early Atherogenesis in Cholesterol-Fed Rabbits. | 2020 | Details |
| A08597 | 32045507 | Mol Nutr Food Res | Lactose, Maltose, and Sucrose in Health and Disease. | 2020 | Details |
| A08609 | 32043602 | Aliment Pharmacol Ther | Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A08645 | 32033765 | Gastroenterol Clin North Am | Nutrition and Nonalcoholic Fatty Liver Disease: Current Perspectives. | 2019 | Details |
| A08649 | 32033761 | Gastroenterol Clin North Am | Similarities and Differences Between Nonalcoholic Steatohepatitis and Other Causes of Cirrhosis. | 2019 | Details |
| A08650 | 32033760 | Gastroenterol Clin North Am | Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A08655 | 32031871 | Am J Physiol Heart Circ Physiol | Gut microbiome of a porcine model of metabolic syndrome and HF-pEF. | 2020 | Details |
| A08662 | 32029233 | Mol Metab | Hepatic ERα accounts for sex differences in the ability to cope with an excess of dietary lipids. | 2019 | Details |
| A08677 | 32025167 | J Clin Exp Hepatol | Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review. | 2019 | Details |
| A08685 | 32022950 | J Eur Acad Dermatol Venereol | The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis. | 2020 | Details |
| A08687 | 32021375 | J Inflamm Res | Saturated Fatty Acids in Obesity-Associated Inflammation. | 2020 | Details |
| A08688 | 32020961 | Med J Armed Forces India | The good, the bad, and the ugly facets of insulin resistance. | 2020 | Details |
| A08693 | 32020371 | Curr Atheroscler Rep | Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis. | 2020 | Details |
| A08701 | 32017891 | Am J Med | Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know? | 2020 | Details |
| A08710 | 32015930 | Liver Res | The acidic pathway of bile acid synthesis: Not just an alternative pathway☆. | 2019 | Details |
| A08727 | 32010250 | Exp Ther Med | Integrated microRNA and proteome analysis reveal a regulatory module in hepatic lipid metabolism disorders in mice with subclinical hypothyroidism. | 2019 | Details |
| A08730 | 32008226 | Aging Clin Exp Res | Prognostic value of non-alcoholic fatty liver disease in the elderly patients. | 2020 | Details |
| A08732 | 32007822 | J Nutr Biochem | Effects of (-)-epicatechin on the time course of the expression of perilipins in a diet-induced model of nonalcoholic steatohepatitis. | 2019 | Details |
| A08734 | 32007335 | Nutr Metab Cardiovasc Dis | Addition of fish oil to atherogenic high fat diet inhibited atherogenesis while olive oil did not, in LDL receptor KO mice. | 2019 | Details |
| A08735 | 32006558 | Metabolism | Complications, morbidity and mortality of nonalcoholic fatty liver disease. | 2020 | Details |
| A08737 | 32006266 | Adv Exp Med Biol | Glucose Lowering Efficacy and Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitors. | 2021 | Details |
| A08743 | 32003679 | Curr Pharm Des | Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State? | 2020 | Details |
| A08744 | 32003662 | Curr Pharm Des | Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD). | 2020 | Details |
| A08749 | 32001430 | Wiad Lek | Correction of adipocyte secretion disorders in patients with non-alcoholic fatty liver disease with overweight and obesity | 2019 | Details |
| A08752 | 32000955 | J Am Coll Cardiol | Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review. | 2020 | Details |
| A08776 | 31987796 | Gastroenterology | Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |